Track the Xvivo Perfusion Aktiebolag stock price and the full insider trade history of the company, a listed equity based in Finland. Shares are quoted on the FI market, under the oversight of FIN-FSA. Operating in the Health Care sector, Xvivo Perfusion Aktiebolag has recorded 10 reports. Market capitalisation: €8.1bn. The latest transaction was filed on 22 July 2026 (Purchase). Among the most active insiders: Gösta Johannesson. The full history is accessible without an account.
10
Insider Decl.
n/a
Thresholds
€221,676
10 ops.
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Xvivo Perfusion Aktiebolag Strong Buy (bullish), based on 5 analysts. Average price target: SEK 335.60.
35Σ signal
Buys €221,676n/a Sells
Fundamental score
Ranked 17,540 of 29,055 companies
45.7
score / 100
Value
33
Quality
59
FCF yld-1.8%
Earn yld0.3%
EV/EBITDA·
ROE4.1%
Gross mgn74%
Net mgn3.1%
Debt/EBITDA1.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
1,000 shares@ €28.78560.0003% mcap100.0% of flowAktieISINISIN SE0004840718FI:A003O168-1
10 of 10 declarations
About Xvivo Perfusion Aktiebolag
Xvivo Perfusion Aktiebolag is a company focused on developing perfusion technologies for transplanted organs. It is listed on the Stockholm Stock Exchange (XSTO).